
Vikas Lifecare Reports Consolidated Results for FY 2026; Highlights Strategic Investments and Asset Sales
Vikas Lifecare Limited has announced its audited consolidated financial results for the quarter and full financial year ended March 31, 2026. The company reported Total Income of ₹63,510.33 Lakhs and a Net Profit for the period of ₹1,836.19 Lakhs.The consolidated statements reflect various major operational activities, including the disposal of two key assets and significant transactions related to investments.
Operational Highlights and Financial Standing
As per the consolidated results, Vikas Lifecare's business segments include Trading & Manufacturing Division -Agro, Trading & Manufacturing Division -Polymers, Trading Division -Infrastructure, and Trading Division- Gas Meter. The company’s financial structure includes Total Assets of ₹76,010.83 Lakhs at year-end.Key corporate transactions detailed in the results include:
- Debenture Settlement: The company executed a Settlement Agreement with Hallow Securities Private Limited (HSPL) regarding debentures aggregating to ₹52.00 crore. The settlement covered the principal amount and included an additional lumpsum compensation of ₹3.00 crore.
- Subsidiary Disposal: Vikas Lifecare disposed of its entire investment, representing 51.38% equity shareholding in Shashi Beriwal and Co Private Limited for a consideration of ₹4.15 crores. This disposal led to the recognition of a loss of ₹7.06 crores.
- Property Sale: The company also disposed of immovable property situated at Arihant Nagar, Delhi, for an aggregate consideration of ₹3.00 crore, resulting in a recognized loss of ₹2.56 crore due to the carrying amount exceeding the sale consideration.
Strategic Investments and Litigation Matters
The company holds a substantial investment through its consortium led by Eraaya Lifespaces Limited (ELL) concerning Ebix Inc. The company contributed INR 2,977.27 million (equivalent US$ 34.83 million) toward the acquisition of Ebix Inc. Following a settlement deed in Q ended June 30, 2025, Vikas Lifecare received 51% equity shares of Ebix International Holdings Limited (EIHL), which is accounted for as an associate using the equity method.The financial results also reflect several ongoing disputes and commitments:
- Advance Impairment: The company recognized an impairment loss on a advance of Rs. 5.00 crore paid toward a proposed acquisition of Abhhyam Services Private Limited, as the conditions precedent under the Memorandum of Understanding (MOU) were not achieved. Legal proceedings have been initiated to seek recovery of the advanced amount.
- Regulatory Matters: The company is pursuing legal remedies regarding the provisional attachment order issued by the Enforcement Directorate concerning certain immovable properties with an approximate purchase value of ₹1,333.84 lakhs. Additionally, SEBI is conducting an ongoing investigation related to certain matters concerning the company.
Audit Opinion and Qualification Details
The audited consolidated financial results carry a Qualified Opinion from KSMC & Associates Chartered Accountants. The basis for this qualification relates to two factors: delays in the deposit of statutory dues by the Parent Company and material related party transactions (RPT) that were undertaken and are awaiting requisite shareholder approval.Management has assured the auditor that these RPTs were conducted on an arm’s length basis, and the company is in the process of obtaining the necessary shareholder approvals. The management assessed that the impact of these qualifications is not currently material or quantifiable to the consolidated financial results.
VIKASLIFE Stock Price Movement
Today, shares of Vikas Lifecare Limited shed value, slipping 0.70% to close at ₹1.40 after trading for the day. The stock recorded a total traded volume of 2.22 million shares.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.